HEOR and market access evidence
Value dossiers, economic models, and payer-ready narratives aligned to HTA and reimbursement requirements across major markets.
Learn moreGlobal health research consultancy
Evidence that travels from bench to policy
Evidence strategy, HEOR, and real-world insights for medicines and public health programs worldwide.
- 40+ markets
- Aligned HTA and access submissions
- End-to-end
- From protocol design to plain language summaries
Services built for complex evidence questions
From HEOR and synthesis to pragmatic RWE programs, we align technical depth with how decisions are actually made.
Real-world evidence strategy
Fit-for-purpose study designs, data partner selection, and transparent reporting that connects RWE to regulatory and access decisions.
Learn moreEvidence synthesis
Systematic reviews, indirect treatment comparisons, and network meta-analyses with protocols built for scientific and policy scrutiny.
Learn moreGlobal operations and delivery
Cross-functional program leadership from protocol to lock, with quality systems that keep timelines credible and data defensible.
Learn moreWhy teams choose Meridian
We combine scientific rigor with consultancy judgment so evidence plans survive real-world scrutiny.
Global perspective, local execution
Teams in North America, Europe, and Asia-Pacific time zones with shared methods and a single scientific steering model.
Decision-grade evidence
We optimize for what reviewers and payers actually challenge: transparency, heterogeneity, and plausible alternatives.
Operational discipline
Milestones, risk registers, and cross-functional rehearsals so evidence plans survive real-world timelines.
Tell us about your evidence challenge
Share your timelines, markets, and decision points. We will respond within two business days with a concise view on fit and next steps.
Ready for a focused conversation?
Whether you are shaping a filing plan or refreshing a post-launch evidence portfolio, we will meet you with clarity and pace.